Belimumab In Prevention of LN

Clinical trial NCT05585671 · UNKNOWN

Trial details

NCT number: NCT05585671
Sponsor: RenJi Hospital
Status: UNKNOWN
Study type: OBSERVATIONAL

Whether Belimumab Could Reduce 2-year Risk of New-onset Lupus Nephritis

Start date: 2023-06-01
Primary completion: 2023-06-01
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.